We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pepsinogen and Serum IgG Detection Is a Valuable Diagnostic Method for Helicobacter pylori Infection in a Low-Prevalence Country: A Report from Sri Lanka.
- Authors
Doohan, Dalla; Fauzia, Kartika Afrida; Rathnayake, Jeewantha; Lamawansa, Meegahalande Durage; Waskito, Langgeng Agung; Tuan, Vo Phuoc; Dashdorj, Azzaya; Kabamba, Evariste Tshibangu; Phuc, Bui Hoang; Ansari, Shamshul; Akada, Junko; Matsumoto, Takashi; Uchida, Tomohisa; Matsuhisa, Takeshi; Yamaoka, Yoshio
- Abstract
The use of serum anti-Helicobacter pylori IgG and pepsinogen (PG) detection as a diagnostic method was evaluated in Sri Lanka. Gastric biopsies were performed (353 patients), and the prevalence of H. pylori infection was 1.7% (culture) and 2.0% (histology). IgG serology testing showed an area under the curve (AUC) of 0.922 (cut-off, 2.95 U/mL; specificity, 91.56%; sensitivity, 88.89%). Histological evaluation showed mild atrophy (34.3%), moderate atrophy (1.7%), metaplasia (1.7%), chronic gastritis (6.2%), and normal tissue (56%). The PGI/PGII ratio was significantly higher in H. pylori-negative patients (p < 0.01). PGII and PGI/PGII levels were lower in patients with metaplasia than in those with normal mucosa (p = 0.049 and p < 0.001, respectively). The PGI/PGII ratio best discriminated metaplasia and moderate atrophy (AUC 0.88 and 0.76, respectively). PGI and PGII alone showed poor discriminative ability, especially in mild atrophy (0.55 and 0.53, respectively) and chronic gastritis (0.55 and 0.53, respectively). The best cut-off to discriminate metaplasia was 3.25 U/mL (95.19% specificity, 83.33% sensitivity). Anti-H. pylori IgG and PG assessment (ABC method) was performed (group B, 2.0%; group A, 92.1%). The new cut-off more accurately identified patients with metaplasia requiring follow-up (group B, 5.4%). Assessment of anti-H. pylori IgG and PG is valuable in countries with a low prevalence of H. pylori infection.
- Subjects
SRI Lanka; HELICOBACTER pylori infections; IMMUNOGLOBULIN G; PEPSINOGEN; HISTOLOGY; HELICOBACTER pylori
- Publication
Diagnostics (2075-4418), 2021, Vol 11, Issue 8, p1364
- ISSN
2075-4418
- Publication type
Article
- DOI
10.3390/diagnostics11081364